SWK Holdings Corporation 9.00% Senior Notes due 2027
SWKHL
NASDAQ Global Market25.62
USD
+0.02
- -
CIK
0001089907
ISIN
US78501P3029
CUSIP
78501P302
Return %
Stock
S&P500
1Y
0.34
26.57
3Y
3.76
76.60
5Y
3.76
78.48
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Jody. D Staggs
- Full Time Employees
- 24
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 14755 Preston Road Dallas TX United States of America 75254
- IPO Date
- Oct 4, 2023
- CIK
- 0001089907
- Website
- swkhold.com
- Similar Companies
- Business
- SWK Holdings Corporation serves as a diversified financial services company focused on providing structured debt and equity financing solutions to life sciences companies, medical device manufacturers, and healthcare service providers. The company offers senior and subordinated debt financing; royalty monetization and acquisition services; equity investments in private and public companies; and lending services through its subsidiaries, including SWK Funding LLC and Palantir Technologies Inc. (no relation to the technology firm). Headquartered in King of Prussia, Pennsylvania, SWK Holdings was founded in 1997 as a spin-off from Stanley Works and operates primarily in the United States with investments spanning North America. Its target markets include biotechnology firms, pharmaceutical developers, and healthcare innovators seeking non-dilutive capital. In recent developments, SWK Holdings issued 9.00% Senior Notes due 2027 (ticker: SWKHL) to bolster its lending capacity; expanded its portfolio through new royalty acquisitions in the biopharma sector in 2024; and formed strategic lending partnerships with emerging medtech companies amid rising demand for specialized financing.